Disparities in participation in cancer clinical trials in the United States
Open Access
Abstract
Disparities in minorities' representation in cancer clinical trials have been shown only in adult populations, which suggest that the main causes of these disparities relate to health system‐based barriers, including issues of poverty (lack of insurance), poor access to trials, and an inadequate number of clinical trials. Initiatives that increase the participation of community physicians in cancer clinical research trials and increase low socioeconomic status patients' access to cancer trials will likely ameliorate this problem. Cancer 2008. © 2007 American Cancer Society.Keywords
This publication has 12 references indexed in Scilit:
- Dasatinib Induces a Response in Malignant ThymomaJournal of Clinical Oncology, 2006
- Increasing Minority Participation in Cancer Clinical Trials: The Minority-Based Community Clinical Oncology Program ExperienceJournal of Clinical Oncology, 2005
- Insurance and the U.S. Health Care SystemNew England Journal of Medicine, 2005
- Impact of Managed Care on Cancer Trial EnrollmentJournal of Clinical Oncology, 2005
- Insured But Not Protected: How Many Adults Are Underinsured?Health Affairs, 2005
- Participation in Cancer Clinical TrialsJAMA, 2004
- Participation of Patients 65 Years of Age or Older in Cancer Clinical TrialsJournal of Clinical Oncology, 2003
- The Consequences of Premature Abandonment of Affirmative Action in Medical School AdmissionsJAMA, 2003
- How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment TrialsJournal of Clinical Oncology, 2002
- The Role of Black and Hispanic Physicians in Providing Health Care for Underserved PopulationsNew England Journal of Medicine, 1996